Indications

Protectival is a unique, multi-targeted, natural, bio-active, botanical compound based on many years of clinical experience and research. With over 200 pre-clinical studies conducted, experiments have shown Protectival to:

• Reduce chemotherapy side effects (randomized clinical trial)
• Inhibit proliferation and promote apoptosis of cancer cells (pre-clinical trials)
• Support the immune system (clinical trials & pre-clinical trials)
• Improve quality of life during treatment (clinical trial )

Ingredients

Active Ingrdients:

Astragalus Membranaceus
Scutellaria Barbata
Oldenlandia Diffusa
Ligustrum Lucidum
Poriae Cocos
Prunella Vulgaris
Citrus Reticulata
Ophiopogon Japonicus
Milletia Reticulata
Atractylodes Macrocephala
Paeonia Lactiflora
Paeonia Obovata
Lycium Chinense
Glehnia Littoralis

Description

The rationale behind Protectival formulation is based on ancient medicinal knowledge which divides herbs into categories. each one was verified by scientific research. The herbs were chosen for their synergic effect from the following categories:
- Destroying unhealthy cells
- Enhancing the immune system
- Reducing side effects, protecting the body from toxins.

In addition to the wide body of knowledge regarding its individual ingredients, Protectival™ is designed to synergize its constituent herbs, making the combined effect greater than that of its individual components. It was subjected to rigorous testing, including a randomized, controlled, double blind clinical test in breast cancer patients receiving chemotherapy in an oncology department, at the Sourasky medical center in Tel-Aviv, Israel. The study has demonstrated in a statistically significant and clinically meaningful way that Protectival™ is safe and effective, and its results have been published in one of the most prestigious peer reviewed oncology journals(1).

At Refuot integrative medical centre, breast cancer patients undergoing chemotherapy were assessed prospectively, showing great improvement in quality-of-life (QOL) when compared with expected outcome of QOL during chemotherapy. The following categories were evaluated:
fatigue; weakness; pain; nausea; vomiting.Clinical outcome: Most (70%) reported none to mild severity of fatigue;
60% none to mild weakness; 85% none to mild pain; 70% none to mild
nausea; and 80% none to mild vomiting. 85% reported that they felt that
Protectival helped reduce their symptoms. No toxic effects were attributed by patients to the treatment (2).

The clinical trials and resulting publication, in addition to over 200 preclinical trials, and the rigorous manufacturing and quality assurance process, were designed to ensure the safety and effectiveness of Protectival™, and differentiate it from other supplements and nutraceuticals in the market.

Quantity

90 tablets

Dose

Pre chemotherapy: 2 tablets/ 3 times per day

During chemotherapy: 2 tablets/ 3 times per day

Post chemotherapy (first month): 2 tablets/ 3 times per day

Maintenance dose: 1 tablet/ 3 times per day

Potential side effects/Safety

Consult a health care practitioner prior to use. Do not take if you are pregnant or breastfeeding. Discontinue use and consult a medical doctor if you experience nausea, vomiting or abdominal pains.

References

"Show references"

"Hide references"

1. Sun JY, Yang H, Miao S, Li JP, Wang SW, Zhu MZ, Xie YH, Wang JB, Liu Z, Yang Q: Suppressive effects of swainsonine on C6 glioma cell in vitro and in vivo. Phytomedicine 2009, 16(11):1070-1074.
2. Cho WC, Leung KN: In vitro and in vivo anti-tumor effects of Astragalus membranaceus. Cancer Lett 2007, 252(1):43-54.
3. Brush J, Mendenhall E, Guggenheim A, Chan T, Connelly E, Soumyanath A, Buresh R, Barrett R, Zwickey H: The effect of Echinacea purpurea, Astragalus
membranaceus and Glycyrrhiza glabra on CD69 expression and immune cell activation in humans. Phytother Res 2006, 20(8):687-695.
4. Sun Y, Hersh EM, Talpaz M, Lee SL, Wong W, Loo TL, Mavligit GM: Immune restoration and/or augmentation of local graft versus host reaction by
traditional Chinese medicinal herbs. Cancer 1983, 52(1):70-73.
5. Zhao KS, Mancini C, Doria G: Enhancement of the immune response in mice by Astragalus membranaceus extracts. Immunopharmacology 1990, 20(3):225-
233.
6. Cho WC, Leung KN: In vitro and in vivo immunomodulating and immunorestorative effects of Astragalus membranaceus. J Ethnopharmacol 2007,
113(1):132-141.
7. Rittenhouse JR, Lui PD, Lau BH: Chinese medicinal herbs reverse macrophage suppression induced by urological tumors. J Urol 1991, 146(2):486-490.
8. Xu HD, You CG, Zhang RL, Gao P, Wang ZR: Effects of Astragalus polysaccharides and astragalosides on the phagocytosis of Mycobacterium tuberculosis
by macrophages. J Int Med Res 2007, 35(1):84-90.
9. Yoshida Y, Wang MQ, Liu JN, Shan BE, Yamashita U: Immunomodulating activity of Chinese medicinal herbs and Oldenlandia diffusa in particular. Int J
Immunopharmacol 1997, 19(7):359-370.
10. Chu DT, Lepe-Zuniga J, Wong WL, LaPushin R, Mavligit GM: Fractionated extract of Astragalus membranaceus, a Chinese medicinal herb, potentiates LAK
cell cytotoxicity generated by a low dose of recombinant interleukin-2. J Clin Lab Immunol 1988, 26(4):183-187.
11. Wang Y, Qian XJ, Hadley HR, Lau BH: Phytochemicals potentiate interleukin-2 generated lymphokine-activated killer cell cytotoxicity against murine
renal cell carcinoma. Mol Biother 1992, 4(3):143-146.
12. Clement-Kruzel S, Hwang SA, Kruzel MC, Dasgupta A, Actor JK: Immune modulation of macrophage pro-inflammatory response by goldenseal and
Astragalus extracts. J Med Food 2008, 11(3):493-498.
13. Ryu M, Kim EH, Chun M, Kang S, Shim B, Yu YB, Jeong G, Lee JS: Astragali Radix elicits anti-inflammation via activation of MKP-1, concomitant with
attenuation of p38 and Erk. J Ethnopharmacol 2008, 115(2):184-193.
14. Zhu XL, Zhu BD: Mechanisms by which Astragalus membranaceus injection regulates hematopoiesis in myelosuppressed mice. Phytother Res 2007,
21(7):663-667.
15. Chu DT, Wong WL, Mavligit GM: Immunotherapy with Chinese medicinal herbs. II. Reversal of cyclophosphamide-induced immune suppression by
administration of fractionated Astragalus membranaceus in vivo. J Clin Lab Immunol 1988, 25(3):125-129.
16. Chu DT, Wong WL, Mavligit GM: Immunotherapy with Chinese medicinal herbs. I. Immune restoration of local xenogeneic graft-versus-host reaction in
cancer patients by fractionated Astragalus membranaceus in vitro. J Clin Lab Immunol 1988, 25(3):119-123.
17. Luo Z, Zhong L, Han X, Wang H, Zhong J, Xuan Z: Astragalus membranaceus prevents daunorubicin-induced apoptosis of cultured neonatal cardiomyocytes: role of free radical effect of Astragalus membranaceus on daunorubicin cardiotoxicity. Phytother Res 2009, 23(6):761-767.
18. Li Y, Liu X, Xue SZ: Antidotal effect of glucoside extracted from Astragalus membranaceus on dimethoate intoxication in guinea pigs. Med Lav 1998, 89 Suppl 2:S136-141.
19. Zhang L, Yang Y, Wang Y, Gao X: Astragalus membranaceus extract promotes neovascularisation by VEGF pathway in rat model of ischemic injury. Pharmazie, 66(2):144-150.
20. Cui R, He J, Wang B, Zhang F, Chen G, Yin S, Shen H: Suppressive effect of Astragalus membranaceus Bunge on chemical hepatocarcinogenesis in rats. Cancer Chemother Pharmacol 2003, 51(1):75-80.
21. Sheng BW, Chen XF, Zhao J, He DL, Nan XY: Astragalus membranaceus reduces free radical-mediated injury to renal tubules in rabbits receiving high- energy shock waves. Chin Med J (Engl) 2005, 118(1):43-49.
22. Wong BY, Lau BH, Tadi PP, Teel RW: Chinese medicinal herbs modulate mutagenesis, DNA binding and metabolism of aflatoxin B1. Mutat Res 1992, 279(3):209-216.
23. Huang HL, Chen CC, Yeh CY, Huang RL: Reactive oxygen species mediation of baizhu-induced apoptosis in human leukemia cells. J Ethnopharmacol 2005, 97(1):21-29.
24. Kim SH, Jung HN, Lee KY, Kim J, Lee JC, Jang YS: Suppression of Th2-type immune response-mediated allergic diarrhea following oral administration of traditional Korean medicine: Atractylodes macrocephala Koidz. Immunopharmacol Immunotoxicol 2005, 27(2):331-343.
25. Kang SA, Park HJ, Kim MJ, Lee SY, Han SW, Leem KH: Citri Reticulatae Viride Pericarpium extract induced apoptosis in SNU-C4, human colon cancer cells. J Ethnopharmacol 2005, 97(2):231-235.
26. Kim MJ, Park HJ, Hong MS, Park HJ, Kim MS, Leem KH, Kim JB, Kim YJ, Kim HK: Citrus Reticulata blanco induces apoptosis in human gastric cancer cells SNU- 668. Nutr Cancer 2005, 51(1):78-82.
27. Ho SC, Lin CC: Investigation of heat treating conditions for enhancing the anti-inflammatory activity of citrus fruit (Citrus reticulata) peels. J Agric Food Chem 2008, 56(17):7976-7982.
28. Jung KH, Ha E, Kim MJ, Won HJ, Zheng LT, Kim HK, Hong SJ, Chung JH, Yim SV: Suppressive effects of nitric oxide (NO) production and inducible nitric oxide synthase (iNOS) expression by Citrus reticulata extract in RAW 264.7 macrophage cells. Food Chem Toxicol 2007, 45(8):1545-1550.
29. Zhou XM, Huang MM, He CC, Li JX: Inhibitory effects of citrus extracts on the experimental pulmonary fibrosis. J Ethnopharmacol 2009, 126(1):143-148.
30. Xu GH, Chen JC, Liu DH, Zhang YH, Jiang P, Ye XQ: Minerals, phenolic compounds, and antioxidant capacity of citrus peel extract by hot water. J Food Sci
2008, 73(1):C11-18.
31. Xu RH, Peng XE, Chen GZ, Chen GL: Effects of cordyceps sinensis on natural killer activity and colony formation of B16 melanoma. Chin Med J (Engl) 1992,
105(2):97-101.
32. Yoon T, Cheon MS, Lee AY, Lee do Y, Moon BC, Chun JM, Choo BK, Kim HK: Anti-inflammatory activity of methylene chloride fraction from Glehnia
littoralis extract via suppression of NF-kappa B and mitogen-activated protein kinase activity. J Pharmacol Sci 2010, 112(1):46-55.
33. Yoon T, Lee do Y, Lee AY, Choi G, Choo BK, Kim HK: Anti-inflammatory effects of Glehnia littoralis extract in acute and chronic cutaneous inflammation.
Immunopharmacol Immunotoxicol 2010, 32(4):663-670.
34. Jeong JC, Kim JW, Kwon CH, Kim TH, Kim YK: Fructus ligustri lucidi extracts induce human glioma cell death through regulation of Akt/mTOR pathway in
vitro and reduce glioma tumor growth in U87MG xenograft mouse model. Phytother Res 2011, 25(3):429-434.
35. An HJ, Jeong HJ, Um JY, Park YJ, Park RK, Kim EC, Na HJ, Shin TY, Kim HM, Hong SH: Fructus Ligustrum lucidi inhibits inflammatory mediator release through
inhibition of nuclear factor-kappaB in mouse peritoneal macrophages. J Pharm Pharmacol 2007, 59(9):1279-1285.
36. Ha KT, Yoon SJ, Choi DY, Kim DW, Kim JK, Kim CH: Protective effect of Lycium chinense fruit on carbon tetrachloride-induced hepatotoxicity. J
Ethnopharmacol 2005, 96(3):529-535.
37. Zhang R, Kang KA, Piao MJ, Kim KC, Kim AD, Chae S, Park JS, Youn UJ, Hyun JW: Cytoprotective effect of the fruits of Lycium chinense Miller against
oxidative stress-induced hepatotoxicity. J Ethnopharmacol 2010, 130(2):299-306.
38. Hsu HY, Yang JJ, Ho YH, Lin CC: Difference in the effects of radioprotection between aerial and root parts of Lycium chinense. J Ethnopharmacol 1999,
64(2):101-108.
39. Hsu CC, Hsu CL, Tsai SE, Fu TY, Yen GC: Protective effect of Millettia reticulata Benth against CCl(4)-induced hepatic damage and inflammatory action in
rats. J Med Food 2009, 12(4):821-828.
40. Gupta S, Zhang D, Yi J, Shao J: Anticancer activities of Oldenlandia diffusa. J Herb Pharmacother 2004, 4(1):21-33.
41. Wong BY, Lau BH, Jia TY, Wan CP: Oldenlandia diffusa and Scutellaria barbata augment macrophage oxidative burst and inhibit tumor growth. Cancer
Biother Radiopharm 1996, 11(1):51-56.
42. Shan BE, Yoshida Y, Sugiura T, Yamashita U: Stimulating activity of Chinese medicinal herbs on human lymphocytes in vitro. Int J Immunopharmacol 1999,
21(3):149-159.
43. Kim SJ, Chung WS, Kim SS, Ko SG, Um JY: Antiinflammatory effect of Oldenlandia diffusa and its constituent, hentriacontane, through suppression of
caspase-1 activation in mouse peritoneal macrophages. Phytother Res 2011, 25(10):1537-1546.
44. Chung HS, Jeong HJ, Hong SH, Kim MS, Kim SJ, Song BK, Jeong IS, Lee EJ, Ahn JW, Baek SH et al: Induction of nitric oxide synthase by Oldenlandia diffusa in
mouse peritoneal macrophages. Biol Pharm Bull 2002, 25(9):1142-1146.
45. Wong BY, Lau BH, Teel RW: Chinese medicinal herbs modulate mutagenesis, DNA binding and metabolism of benzo[a]pyrene 7,8-dihydrodiol and
benzo[a]pyrene 7,8-dihydrodiol-9,10-epoxide. Cancer Lett 1992, 62(2):123-131.
46. Wong BY, Lau BH, Yamasaki T, Teel RW: Inhibition of dexamethasone-induced cytochrome P450-mediated mutagenicity and metabolism of aflatoxin B1
by Chinese medicinal herbs. Eur J Cancer Prev 1993, 2(4):351-356.
47. Song YH, Jeong SJ, Kwon HY, Kim B, Kim SH, Yoo DY: Ursolic acid from Oldenlandia diffusa induces apoptosis via activation of caspases and
phosphorylation of glycogen synthase kinase 3 beta in SK-OV-3 ovarian cancer cells. Biol Pharm Bull, 35(7):1022-1028.
48. Kou J, Sun Y, Lin Y, Cheng Z, Zheng W, Yu B, Xu Q: Anti-inflammatory activities of aqueous extract from Radix Ophiopogon japonicus and its two
constituents. Biol Pharm Bull 2005, 28(7):1234-1238.
49. David Winston, Steven Maimes : book Adaptogens: Herbs for Strength, Stamina, and Stress Relief .Bear & Co, Mar 22, 2007
50. Wang Y, Yan T, Shen J, Guo H, Xiang X: Preventive effect of Ophiopogon japonicus polysaccharides on an autoallergic mouse model for Sjogren's
syndrome by regulating the Th1/Th2 cytokine imbalance. J Ethnopharmacol 2007, 114(2):246-253.
51. Ou TT, Wu CH, Hsu JD, Chyau CC, Lee HJ, Wang CJ: Paeonia lactiflora Pall inhibits bladder cancer growth involving phosphorylation of Chk2 in vitro and in
vivo. J Ethnopharmacol 2011, 135(1):162-172.
52. Fuchs SM, Heinemann C, Schliemann-Willers S, Hartl H, Fluhr JW, Elsner P: Assessment of anti-inflammatory activity of Poria cocos in sodium lauryl
sulphate-induced irritant contact dermatitis. Skin Res Technol 2006, 12(4):223-227.
53. Giner-Larza EM, Manez S, Giner-Pons RM, Carmen Recio M, Rios JL: On the anti-inflammatory and anti-phospholipase A(2) activity of extracts from
lanostane-rich species. J Ethnopharmacol 2000, 73(1-2):61-69.
54. Yu SJ, Tseng J: Fu-Ling, a Chinese herbal drug, modulates cytokine secretion by human peripheral blood monocytes. Int J Immunopharmacol 1996,
18(1):37-44.
55. Feng L, Jia X, Zhu M, Chen Y, Shi F: Chemoprevention by Prunella vulgaris L. extract of non-small cell lung cancer via promoting apoptosis and regulating
the cell cycle. Asian Pac J Cancer Prev 2010, 11(5):1355-1358.
56. Feng L, Jia XB, Jiang J, Zhu MM, Chen Y, Tan XB, Shi F: Combination of active components enhances the efficacy of Prunella in prevention and treatment of
lung cancer. Molecules 2010, 15(11):7893-7906.
57. Choi JH, Han EH, Hwang YP, Choi JM, Choi CY, Chung YC, Seo JK, Jeong HG: Suppression of PMA-induced tumor cell invasion and metastasis by aqueous
extract isolated from Prunella vulgaris via the inhibition of NF-kappaB-dependent MMP-9 expression. Food Chem Toxicol 2010, 48(2):564-571.
58. Huang N, Hauck C, Yum MY, Rizshsky L, Widrlechner MP, McCoy JA, Murphy PA, Dixon PM, Nikolau BJ, Birt DF: Rosmarinic acid in Prunella vulgaris ethanol
extract inhibits lipopolysaccharide-induced prostaglandin E2 and nitric oxide in RAW 264.7 mouse macrophages. J Agric Food Chem 2009, 57(22):10579-
10589.
59. Zdarilova A, Svobodova A, Simanek V, Ulrichova J: Prunella vulgaris extract and rosmarinic acid suppress lipopolysaccharide-induced alteration in human
gingival fibroblasts. Toxicol In Vitro 2009, 23(3):386-392.
60. Han EH, Choi JH, Hwang YP, Park HJ, Choi CY, Chung YC, Seo JK, Jeong HG: Immunostimulatory activity of aqueous extract isolated from Prunella vulgaris.
Food Chem Toxicol 2009, 47(1):62-69.
61. Fong S, Shoemaker M, Cadaoas J, Lo A, Liao W, Tagliaferri M, Cohen I, Shtivelman E: Molecular mechanisms underlying selective cytotoxic activity of
BZL101, an extract of Scutellaria barbata, towards breast cancer cells. Cancer Biol Ther 2008, 7(4):577-586.
62. Klawitter J, Klawitter J, Gurshtein J, Corby K, Fong S, Tagliaferri M, Quattrochi L, Cohen I, Shtivelman E, Christians U: Bezielle (BZL101)-induced oxidative
stress damage followed by redistribution of metabolic fluxes in breast cancer cells: a combined proteomic and metabolomic study. Int J Cancer 2011,
129(12):2945-2957.
63. Perez AT, Arun B, Tripathy D, Tagliaferri MA, Shaw HS, Kimmick GG, Cohen I, Shtivelman E, Caygill KA, Grady D et al: A phase 1B dose escalation trial of
Scutellaria barbata (BZL101) for patients with metastatic breast cancer. Breast Cancer Res Treat 2010, 120(1):111-118.
64. Wong BY, Nguyen DL, Lin T, Wong HH, Cavalcante A, Greenberg NM, Hausted RP, Zheng J: Chinese medicinal herb Scutellaria barbata modulates apoptosis
and cell survival in murine and human prostate cancer cells and tumor development in TRAMP mice. Eur J Cancer Prev 2009, 18(4):331-341.
65. Chen V, Staub RE, Baggett S, Chimmani R, Tagliaferri M, Cohen I, Shtivelman E: Identification and analysis of the active phytochemicals from the anti-
cancer botanical extract Bezielle. PLoS One 2012, 7(1):e30107.